SG11201809772QA - Method for the production of molded bodies for administration to animals - Google Patents
Method for the production of molded bodies for administration to animalsInfo
- Publication number
- SG11201809772QA SG11201809772QA SG11201809772QA SG11201809772QA SG11201809772QA SG 11201809772Q A SG11201809772Q A SG 11201809772QA SG 11201809772Q A SG11201809772Q A SG 11201809772QA SG 11201809772Q A SG11201809772Q A SG 11201809772QA SG 11201809772Q A SG11201809772Q A SG 11201809772QA
- Authority
- SG
- Singapore
- Prior art keywords
- animals
- administration
- production
- molded bodies
- shaped articles
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heating, Cooling, Or Curing Plastics Or The Like In General (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
METHOD FOR THE PRODUCTION OF MOLDED BODIES FOR ADMINISTRATION TO ANIMALS 5 The present invention relates to a process for preparing shaped articles for administration to animals, to the shaped articles obtainable according to the process and to their use. Figure 4a 10
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16169374 | 2016-05-12 | ||
PCT/EP2017/060805 WO2017194415A1 (en) | 2016-05-12 | 2017-05-05 | Method for the production of molded bodies for administration to animals |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201809772QA true SG11201809772QA (en) | 2018-12-28 |
Family
ID=55967166
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201912785QA SG10201912785QA (en) | 2016-05-12 | 2017-05-05 | Method for the production of molded bodies for administration to animals |
SG11201809772QA SG11201809772QA (en) | 2016-05-12 | 2017-05-05 | Method for the production of molded bodies for administration to animals |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201912785QA SG10201912785QA (en) | 2016-05-12 | 2017-05-05 | Method for the production of molded bodies for administration to animals |
Country Status (20)
Country | Link |
---|---|
US (1) | US20190110985A1 (en) |
EP (1) | EP3454831A1 (en) |
JP (1) | JP2019514991A (en) |
KR (1) | KR20190008264A (en) |
CN (1) | CN109475493A (en) |
AR (1) | AR108459A1 (en) |
AU (1) | AU2017262630A1 (en) |
BR (1) | BR112018073220A2 (en) |
CA (1) | CA3023794A1 (en) |
CL (1) | CL2018003188A1 (en) |
CO (1) | CO2018012110A2 (en) |
DO (1) | DOP2018000247A (en) |
IL (1) | IL262758A (en) |
MX (1) | MX2018013816A (en) |
PH (1) | PH12018502350A1 (en) |
RU (1) | RU2018143832A (en) |
SG (2) | SG10201912785QA (en) |
TW (1) | TW201806582A (en) |
UY (1) | UY37243A (en) |
WO (1) | WO2017194415A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3878436A1 (en) | 2020-03-09 | 2021-09-15 | Bayer Animal Health GmbH | Soft chewable formed body for the administration to animals |
CN115581695B (en) * | 2022-10-18 | 2023-08-29 | 嘉兴金派特生物科技有限公司 | Application of dimetanidazole in preparing medicine for treating diarrhea of cats, and dimetanidazole preparation for treating diarrhea of cats |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100267576B1 (en) | 1998-07-25 | 2000-11-01 | 허계성 | Chewable soft tablet comprising separated active ingredients and process for preparing the same |
US6270790B1 (en) | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
DE10031044A1 (en) * | 2000-06-26 | 2002-01-03 | Bayer Ag | Endoparasiticidal agents for voluntary oral ingestion by animals |
ES2767173T3 (en) | 2002-08-13 | 2020-06-16 | Intervet Int Bv | Compositions and process to administer an additive |
US20040037869A1 (en) | 2002-08-16 | 2004-02-26 | Douglas Cleverly | Non-animal product containing veterinary formulations |
AU2008201605B2 (en) | 2003-07-30 | 2010-04-29 | Novartis Ag | Palatable ductile chewable veterinary composition |
TWI366442B (en) * | 2003-07-30 | 2012-06-21 | Novartis Ag | Palatable ductile chewable veterinary composition |
EP1602285A1 (en) * | 2004-06-04 | 2005-12-07 | Gaines Treats Limited | A process for preparing a chewable pet food |
US7348027B2 (en) | 2005-04-08 | 2008-03-25 | Bayer Healthcare Llc | Taste masked veterinary formulation |
US7955632B2 (en) * | 2005-12-07 | 2011-06-07 | Bayer B.V. | Process for manufacturing chewable dosage forms for drug delivery and products thereof |
AU2007260887B2 (en) * | 2006-06-21 | 2013-07-18 | Mars, Incorporated | Edible pet chew and method of making the same |
US9155772B2 (en) | 2008-12-08 | 2015-10-13 | Philip Morris Usa Inc. | Soft, chewable and orally dissolvable and/or disintegrable products |
JP5289409B2 (en) * | 2010-10-05 | 2013-09-11 | 日本製粉株式会社 | Pet food coating composition and semi-moist type or soft dry type pet food using the same |
WO2012049156A1 (en) | 2010-10-12 | 2012-04-19 | Bayer Animal Health Gmbh | Non-starch based soft chewables |
BR112014003506A8 (en) * | 2011-08-15 | 2017-06-20 | Nestec Sa | multi-textured animal meals |
WO2013068371A1 (en) | 2011-11-08 | 2013-05-16 | Intervet International B.V. | Soft chewable dosage form compositions of cannabinoid receptor type 1 (cb-1) antagonists |
-
2017
- 2017-05-05 MX MX2018013816A patent/MX2018013816A/en unknown
- 2017-05-05 CA CA3023794A patent/CA3023794A1/en not_active Abandoned
- 2017-05-05 KR KR1020187035032A patent/KR20190008264A/en not_active Application Discontinuation
- 2017-05-05 JP JP2018558743A patent/JP2019514991A/en active Pending
- 2017-05-05 WO PCT/EP2017/060805 patent/WO2017194415A1/en unknown
- 2017-05-05 AU AU2017262630A patent/AU2017262630A1/en not_active Abandoned
- 2017-05-05 SG SG10201912785QA patent/SG10201912785QA/en unknown
- 2017-05-05 BR BR112018073220-6A patent/BR112018073220A2/en not_active Application Discontinuation
- 2017-05-05 US US16/099,467 patent/US20190110985A1/en not_active Abandoned
- 2017-05-05 SG SG11201809772QA patent/SG11201809772QA/en unknown
- 2017-05-05 RU RU2018143832A patent/RU2018143832A/en not_active Application Discontinuation
- 2017-05-05 CN CN201780043242.0A patent/CN109475493A/en active Pending
- 2017-05-05 EP EP17720832.9A patent/EP3454831A1/en not_active Withdrawn
- 2017-05-10 TW TW106115411A patent/TW201806582A/en unknown
- 2017-05-11 AR ARP170101259A patent/AR108459A1/en unknown
- 2017-05-12 UY UY0001037243A patent/UY37243A/en not_active Application Discontinuation
-
2018
- 2018-11-04 IL IL262758A patent/IL262758A/en unknown
- 2018-11-07 PH PH12018502350A patent/PH12018502350A1/en unknown
- 2018-11-09 CL CL2018003188A patent/CL2018003188A1/en unknown
- 2018-11-09 CO CONC2018/0012110A patent/CO2018012110A2/en unknown
- 2018-11-09 DO DO2018000247A patent/DOP2018000247A/en unknown
Also Published As
Publication number | Publication date |
---|---|
UY37243A (en) | 2017-11-30 |
CO2018012110A2 (en) | 2018-11-22 |
TW201806582A (en) | 2018-03-01 |
BR112018073220A2 (en) | 2019-02-19 |
SG10201912785QA (en) | 2020-02-27 |
US20190110985A1 (en) | 2019-04-18 |
EP3454831A1 (en) | 2019-03-20 |
JP2019514991A (en) | 2019-06-06 |
RU2018143832A3 (en) | 2020-07-27 |
PH12018502350A1 (en) | 2019-09-02 |
MX2018013816A (en) | 2019-03-21 |
KR20190008264A (en) | 2019-01-23 |
CN109475493A (en) | 2019-03-15 |
AR108459A1 (en) | 2018-08-22 |
RU2018143832A (en) | 2020-06-15 |
CA3023794A1 (en) | 2017-11-16 |
AU2017262630A1 (en) | 2018-11-22 |
CL2018003188A1 (en) | 2019-03-01 |
IL262758A (en) | 2018-12-31 |
DOP2018000247A (en) | 2019-01-31 |
WO2017194415A1 (en) | 2017-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10202110186QA (en) | Alloy member, process for producing said alloy member, and product including said alloy member | |
MX2018002206A (en) | Non-toxic plant agent compositions and methods and uses thereof. | |
ZA201707639B (en) | Processes for producing 2,5-furandicarboxylic acid and derivatives thereof and polymers made therefrom | |
EP3278945A4 (en) | Composite material, process for producing composite material, and process for producing molded article | |
MY190659A (en) | Method for producing biohydrocarbons | |
PL3408326T3 (en) | Elastomeric articles, compositions, and methods for their production | |
PT3142785T (en) | Process for the production of alkenols and use thereof for the production of 1,3-butadiene | |
EP3231527A4 (en) | Blank, molded article, mold and method for producing blank | |
IL265319A (en) | Process for preparing 2-exo-(2-methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[2.2.1]heptane | |
EP3626693A4 (en) | Composition for inorganic molded article production use, and method for producing inorganic molded article | |
JOP20200110A1 (en) | Novel Enantiomers of a Series of Antiviral Compounds | |
MX2017003301A (en) | Refractory product, batch composition for producing said product, method for producing the product and use of said product. | |
MX2018002318A (en) | Improved process for producing fucoxanthin and/or polysaccharides from microalgae. | |
IL268266A (en) | Process for preparing 2-exo-(2-methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[2.2.1]heptane | |
TW201613953A (en) | Process for the preparation of cyclic depsipeptides | |
MX2020009447A (en) | Process for the production of a food composition with improved flow-ability. | |
EP3711889A4 (en) | Method for producing molded article, production device, and molded article | |
SG11201809772QA (en) | Method for the production of molded bodies for administration to animals | |
EP3858575C0 (en) | Mould, machine and method for producing three-dimensional articles and production plant associated with same | |
IL269269A (en) | Process for preparing 2-exo-(2-methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[2.2.1]heptane | |
MX2020000003A (en) | Method for producing silicone elastomer moulds. | |
SA518392272B1 (en) | Semifinished Product, Method of Production and Use Thereof | |
MX2017008776A (en) | Batch composition for producing a refractory product, method for producing a refractory product, refractory product, and use of a refractory product. | |
EP3756847A4 (en) | Mold production method, and molded article production method using same | |
GB201722014D0 (en) | Analgesic 2,4,6-trinitro-3,3-dimethyl-5-tert-butylbenzene production plant |